Penumbra, Inc. (PEN): Price and Financial Metrics

Penumbra, Inc. (PEN): $322.37

0.54 (+0.17%)

POWR Rating

Component Grades








Add PEN to Watchlist
Sign Up

PEN Price/Volume Stats

Current price $322.37 52-week high $324.38
Prev. close $321.83 52-week low $114.86
Day low $319.10 Volume 146,600
Day high $322.78 Avg. volume 341,322
50-day MA $295.57 Dividend yield N/A
200-day MA $234.81 Market Cap 12.33B

PEN Stock Price Chart Interactive Chart >


  • PEN scores best on the Growth dimension, with a Growth rank ahead of 98.58% of US stocks.
  • PEN's strongest trending metric is Value; it's been moving down over the last 179 days.
  • PEN's current lowest rank is in the Value metric (where it is better than 14.86% of US stocks).

PEN Stock Summary

  • With a price/earnings ratio of 1,815.38, PENUMBRA INC P/E ratio is greater than that of about 99.66% of stocks in our set with positive earnings.
  • PEN's price/sales ratio is 13.3; that's higher than the P/S ratio of 92.02% of US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, PENUMBRA INC is reporting a growth rate of -166.99%; that's higher than merely 9.66% of US stocks.
  • If you're looking for stocks that are quantitatively similar to PENUMBRA INC, a group of peers worth examining would be PETS, TDW, CINF, HGTY, and AMPS.
  • Visit PEN's SEC page to see the company's official filings. To visit the company's web site, go to

PEN Valuation Summary

  • PEN's price/earnings ratio is 1804.5; this is 7387.55% higher than that of the median Healthcare stock.
  • PEN's EV/EBIT ratio has moved up 2243.3 over the prior 93 months.

Below are key valuation metrics over time for PEN.

Stock Date P/S P/B P/E EV/EBIT
PEN 2023-05-23 13.2 11.4 1804.5 672.3
PEN 2023-05-22 13.8 11.9 1880.8 700.4
PEN 2023-05-19 13.7 11.9 1874.6 698.1
PEN 2023-05-18 13.6 11.8 1859.8 692.7
PEN 2023-05-17 13.6 11.7 1852.0 689.8
PEN 2023-05-16 13.7 11.8 1863.8 694.2

PEN Growth Metrics

    The 4 year revenue growth rate now stands at 99.67%.
  • Its 4 year price growth rate is now at 120.95%.
  • Its year over year cash and equivalents growth rate is now at 22.52%.
Over the past 52 months, PEN's revenue has gone up $426,937,000.

The table below shows PEN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 847.133 -55.661 -2.002
2022-09-30 829.928 -66.268 -30.512
2022-06-30 806.367 -16.909 -19.391
2022-03-31 782.281 19.356 -6.473
2021-12-31 747.59 9.502 5.284
2021-09-30 710.477 16.689 33.565

PEN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PEN has a Quality Grade of C, ranking ahead of 49.95% of graded US stocks.
  • PEN's asset turnover comes in at 0.794 -- ranking 38th of 186 Medical Equipment stocks.
  • IVC, NTUS, and MLSS are the stocks whose asset turnover ratios are most correlated with PEN.

The table below shows PEN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.794 0.618 0.009
2021-03-31 0.728 0.610 -0.030
2020-12-31 0.728 0.603 -0.054
2020-09-30 0.738 0.635 -0.038
2020-06-30 0.774 0.658 0.017
2020-03-31 0.880 0.676 0.079

PEN Price Target

For more insight on analysts targets of PEN, see our PEN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $319.80 Average Broker Recommendation 1.31 (Strong Buy)

Penumbra, Inc. (PEN) Company Bio

Penumbra Inc. is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. The company was founded in 2004 and is based in Alameda, CA.

PEN Latest News Stream

Event/Time News Detail
Loading, please wait...

PEN Latest Social Stream

Loading social stream, please wait...

View Full PEN Social Stream

Latest PEN News From Around the Web

Below are the latest news stories about PENUMBRA INC that investors may wish to consider to help them evaluate PEN as an investment opportunity.

7 High-Flying Stocks Destined to Crash Back to Earth

What goes up must come down (even for outstanding enterprises), which clouds these overvalued stocks due for correction.

Josh Enomoto on InvestorPlace | June 1, 2023

Top Stocks for June 2023

Southwestern Energy, Mirati Therapeutics, and First Solar are top US stocks Russell 3000 in June 2023 for value, growth, and momentum, respectively.

Yahoo | June 1, 2023

Penumbra Expands Computer-Aided Thrombectomy Offerings with Lightning Bolt 7 Technology Designed to Rapidly Remove Blood Clots with Modulated Aspiration

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, announced the U.S. Food and Drug Administration (FDA) clearance and launch of Lightning Bolt™ 7, the most advanced and powerful arterial thrombectomy system on the market. Lightning Bolt 7 introduces a new method for removing blood clots, modulated aspiration, which pairs Penumbra's Lightning Intelligent Aspiration technology with an advanced microprocessor algorithm. When used together, Lightning Bolt 7 is

Yahoo | June 1, 2023

What You Can Learn From Penumbra, Inc.'s (NYSE:PEN) P/S

With a price-to-sales (or "P/S") ratio of 13.3x Penumbra, Inc. ( NYSE:PEN ) may be sending very bearish signals at the...

Yahoo | May 25, 2023

Penumbra, Inc. to Present at William Blair's 43rd Annual Growth Stock Conference

Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at William Blair's 43rd Annual Growth Stock Conference on Wednesday, June 7, 2023.

Yahoo | May 24, 2023

Read More 'PEN' Stories Here

PEN Price Returns

1-mo 3.76%
3-mo 29.11%
6-mo 49.11%
1-year 127.26%
3-year 80.05%
5-year 95.02%
YTD 44.91%
2022 -22.57%
2021 64.18%
2020 6.53%
2019 34.43%
2018 29.86%

Continue Researching PEN

Here are a few links from around the web to help you further your research on Penumbra Inc's stock as an investment opportunity:

Penumbra Inc (PEN) Stock Price | Nasdaq
Penumbra Inc (PEN) Stock Quote, History and News - Yahoo Finance
Penumbra Inc (PEN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!